Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases

Bioorg Med Chem. 2005 Feb 1;13(3):773-83. doi: 10.1016/j.bmc.2004.10.037.

Abstract

Several novel antioxidant-iron chelators bearing 8-hydroxyoxyquinoline moiety were synthesized, and various properties related to their iron chelation, and neuroprotective action were investigated. All the chelators exhibited strong iron(III) chelating and high antioxidant properties. Chelator 9 (HLA20), having good permeability into K562 cells and moderate selective MAO-B inhibitory activity (IC50 110 microM), displayed the hightest protective effects against differentiated P19 cell death induced by 6-hydroxydopamine. EPR studies suggested that Chelator 9 also act as radical scavenger to directly scavenge hydroxyl radical.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Antioxidants / pharmacology
  • Cell Line
  • Cell Membrane Permeability / drug effects
  • Electron Spin Resonance Spectroscopy
  • Free Radical Scavengers / pharmacology
  • Humans
  • Iron Chelating Agents / chemical synthesis*
  • Iron Chelating Agents / chemistry
  • Iron Chelating Agents / pharmacology
  • Iron Chelating Agents / therapeutic use*
  • K562 Cells
  • Magnetic Resonance Spectroscopy
  • Mass Spectrometry
  • Monoamine Oxidase Inhibitors / pharmacology
  • Neurodegenerative Diseases / drug therapy*
  • Neuroprotective Agents / chemical synthesis*
  • Neuroprotective Agents / chemistry
  • Neuroprotective Agents / pharmacology
  • Neuroprotective Agents / therapeutic use*
  • Parkinson Disease / drug therapy*

Substances

  • Antioxidants
  • Free Radical Scavengers
  • Iron Chelating Agents
  • Monoamine Oxidase Inhibitors
  • Neuroprotective Agents